NephroGenex, Inc. 4
4 · NephroGenex, Inc. · Filed Aug 15, 2014
Insider Transaction Report
Form 4
Hamill John
Chief Financial Officer
Transactions
- Award
Options to Purchase Common Stock
2014-08-14+24,000→ 24,000 totalExercise: $4.49→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the options will vest on August 14, 2015, and the remainder of the shares underlying the options will vest on a pro rata monthly basis for a three-year period following August 14, 2015.